The outlook of companies tied to flagship drugs like Viagra presents a nuanced investment landscape . While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the expiry in key markets has introduced significant uncertainty . Investors are now grappling with the effect of lower-cost alternativ